Deep Learning-Based Pathogenicity Classifier for Promoter Single Nucleotide Variants (pSNVs)

Patent №

US 12,619,875

Granted

2026-05-05

Filed 2023

Owner

Illumina, Inc.

Lab

AI components

0

Assignment

None on record

Dataset

AIPD

Application

18513367

We disclose computational models that alleviate the effects of human ascertainment biases in curated pathogenic non-coding variant databases by generating pathogenicity scores for variants occurring in the promoter regions (referred to herein as promoter single nucleotide variants (pSNVs)). We train deep learning networks (referred to herein as pathogenicity classifiers) using a semi-supervised approach to discriminate between a set of labeled benign variants and an unlabeled set of variants that were matched to remove biases.

G06N 20/20G06N 3/08G16B 40/00G06N 3/09G06N 3/0895G06N 3/045G06N 3/0464G06N 3/044+3 more

Ownership

Illumina, Inc.

© 2026 NYSGPT2525 LLC